Biostatistics faculty members Tom Fleming and Betz Halloran sit on the WHO Ad Hoc Expert Group on the Next Steps for COVID-19 Vaccine Evaluation. In a recent New England Journal of Medicine article, the group notes that even though the efficacy of some COVID-19 vaccines appears to be high, reliable information will still be needed on longer-term safety and duration of protection.
News & Events
Latest


Placebo-Controlled Trials of Covid-19 Vaccines — Why We Still Need Them
New England Journal of Medicine,


Thanks to student support funding, 15 current students were able to attend keynote sessions, panel discussions and short courses offered through the 6th Seattle Symposium in Biostatistics: Precision Medicine in the Age of Data Science.


Lead biostatistician Jim Hughes discusses study results and design challenges.


Two core faculty members from the University of Washington Department of Biostatistics in the School of Public Health have been recognized as
No Love for Aducanumab From FDA Advisers — Panel rejects mixed findings for controversial Alzheimer's drug
Medpage Today,
"This analysis seems to be subject to the Texas sharpshooter fallacy," where someone first fires a shot at a barn then paints a target around the bullet hole, said panelist and biostatistician Scott Emerson, MD, PhD, of the University of Washington in Seattle.